"A lot of the medicines we currently have are difficult for people to take, " Underberg says.
FORBES: For Merck, A New Worry Amid Success
2.
"It's going to be a nice addition, " says James Underberg, a New York University lipidologist who participated in the Januvia trials.
FORBES: Diabetes Duel
3.
James Underberg, an NYU cardiologist, complains that drug safety experts are too eager to use studies to answer questions they were not designed to answer.